Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RI vs RASS for Sedation in Critically Ill Patients
NCT03250481Completed
- Sponsor
- Helsinki University Hospital
- Start
- Mar 2013
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of propofol in critical illness, sponsored by Helsinki University Hospital. Primary endpoint: Number of patients with sedation or sedation monitoring related predetermined adverse events at 96 hours. Started Mar 2013; status: completed.
02
Drugs
propofol
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT03250481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03250481.